Menu

• Ask a Health Expert about DYSPNOEA PAROXYSMAL NOCTURNAL
• Post Your Side Effect related to DYSPNOEA PAROXYSMAL NOCTURNAL
• DYSPNOEA PAROXYSMAL NOCTURNAL and FDA Warnings
• DYSPNOEA PAROXYSMAL NOCTURNAL in Patients Wiki
• Report DYSPNOEA PAROXYSMAL NOCTURNAL in Drug Side Effect Survey

DYSPNOEA PAROXYSMAL NOCTURNAL side effect

What is DYSPNOEA PAROXYSMAL NOCTURNAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Ibuprofen Side Effects Report #5261007-8
Health Professional from SPAIN reported IBUPROFEN problem on Feb 21, 2007. Male patient, 70 years of age, was diagnosed with back pain and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: dyspnoea paroxysmal nocturnal, hypertensive emergency, pulmonary oedema, sinus tachycardia, . IBUPROFEN dosage: 600 MG, TID. During the same period patient was treated with TORASEMIDA. Patient recovered.

Ramipril Side Effects Report #5766720-1
RAMIPRIL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2008. Male patient, 79 years of age, weighting 162.0 lb, was treated with RAMIPRIL. After drug was administered, patient experienced the following problems/side effects: cardiac failure, dyspnoea paroxysmal nocturnal, . RAMIPRIL dosage: 2.5 MG/DAY, ORAL. During the same period patient was treated with ALTACE, COZAAR, COREG. Patient recovered.

Ramipril Side Effects Report #5692721-8
Consumer or non-health professional from UNITED STATES reported RAMIPRIL problem on Mar 17, 2008. Male patient, 79 years of age, was treated with RAMIPRIL. After drug was administered, patient experienced the following problems/side effects: cardiac failure, dyspnoea paroxysmal nocturnal, . RAMIPRIL dosage: 2.5 MG/DAY, ORAL. During the same period patient was treated with ALTACE, COZAAR, COREG. Patient recovered.

Pamidronate Side Effects Report #5341510-2
PAMIDRONATE DI problem was reported by a Health Professional from UNITED KINGDOM on May 23, 2007. Male patient, 54 years of age, weighting 149.9 lb, was diagnosed with blood calcium increased and was treated with PAMIDRONATE DI. After drug was administered, patient experienced the following problems/side effects: dyspnoea paroxysmal nocturnal, hypercalcaemia, paraesthesia, . PAMIDRONATE DI dosage: THREE 30-MG DOSES. Patient was hospitalized. Patient recovered.


Revlimid Side Effects Report #5375787-4
Physician from UNITED STATES reported REVLIMID problem on June 19, 2007. Male patient, 63 years of age, was diagnosed with renal cancer metastatic and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anxiety, dyspnoea paroxysmal nocturnal, haemoglobin decreased, malignant neoplasm progression, metastases to bone, metastases to lung, renal cancer metastatic, . REVLIMID dosage: 25 MG, DAILY X 21 DAYS, ORAL. During the same period patient was treated with BLOOD TRANSFUSION. Patient died on 06/05/2007.

Avandamet Side Effects Report #5278609-5
AVANDAMET problem was reported by a Physician from UNITED KINGDOM on Mar 19, 2007. Male patient, 67 years of age, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea paroxysmal nocturnal, hypoxia, left ventricular failure, pulmonary oedema, . AVANDAMET dosage: unknown. During the same period patient was treated with INDAPAMIDE. Patient was hospitalized. Patient recovered.

Avandamet Side Effects Report #5615643-7
Consumer or non-health professional from IRELAND reported AVANDAMET problem on Jan 30, 2008. Male patient, 51 years of age, was diagnosed with diabetes mellitus and was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: cardiac failure, dyspnoea exertional, dyspnoea paroxysmal nocturnal, . AVANDAMET dosage: unknown. Patient recovered.

Namenda Side Effects Report #5629499-X
NAMENDA problem was reported by a Physician from UNITED STATES on Feb 15, 2008. Male patient, 77 years of age, weighting 175.0 lb, was diagnosed with cardiac failure congestive and was treated with NAMENDA. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, condition aggravated, dyspnoea paroxysmal nocturnal, . NAMENDA dosage: unknown. Patient died on 11/09/2007.